JCR Japan College of Rheumatology-
有限責任中間法人 日本リウマチ学会
 
 

トップページ
バックナンバー
学会誌MR
NLリウマチ
メルマガ
旧和文誌
会員へのお知らせ
医療・医薬情報
リウマチ学会TV
住所・勤務先変更
Original Article

Decrease in CD4+CD25+ and CD8+CD28+ T cells in interstitial pneumonitis associated with rheumatic disease

Authors

Akira Katagiri1, Shinji Morimoto1, Yutaka Nakiri1, Souichiro Nakano1, Akiko Mitsuo1, Jun Suzuki1, Hirofumi Amano1, Kazuhisa Nozawa1, Masanao Asano1, Yoshiaki Tokano1, Hiroshi Hashimoto1 and Yoshinari Takasaki1

  1. Department of Internal Medicine and Rheumatology, School of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan
Received:

7 February 2008

Accepted:

7 May 2008

Published online:

19 June 2008

Full Text

PDF

Abstract

The expression of CD25 or CD28 on T cells was examined in patients with rheumatic diseases associated with interstitial pneumonitis (IP), in order to investigate the conditions of CD4+CD25+ regulatory T cells and CD8+CD28- suppressor T cells. Fifty-five patients with various rheumatic diseases and 23 normal controls were enrolled. CD4+CD25+ T cells of patients with IP were significantly decreased in comparison with non-IP patients, and the ratio of CD8+CD28+ T cells in patients with IP was significantly higher than that in non-IP patients or normal controls. These results for CD8+CD28+ T cells were in accord with the decrease in CD8+CD28+ T cells, and may be related to activation-induced CD8+CD28+ T-cell death. Thus, the abnormality of CD4+CD25+ regulatory T cells may be related to the pathogenesis of IP, and the survival and activation of CD8+ T cells.

Key words

CD4+CD25+ regulatory T cell - CD8+CD28+ suppressor T cell - Interstitial pneumonitis - Rheumatic diseases - CD62L


Copyright Japan College of Rheumatology All rights reserved.